[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100564227":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":37,"responsibleParty":84,"collaborators":87,"id":90,"slug":91,"hasResults":92,"nctId":93,"briefTitle":94,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":92,"sex":97,"minAge":98,"maxAge":18,"enrollmentInfo":99,"targetDuration":18,"studyType":102,"phases":103,"briefSummary":105,"conditions":106,"keywords":108,"overallStatus":67,"whyStopped":18,"lastUpdateSubmitDate":113,"lastUpdatePostDateStruct":114,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":122},{"fullName":5,"class":6},"The University of Western Australia","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatable Traits model of care","EXPERIMENTAL","Embedded multidisciplinary clinic. This involves multidimensional assessment of patients with MDT review to determine presence of treatable traits and their specific management.",[13],"Other: Treatable traits model of care",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard of Care","NO_INTERVENTION","Standard of care where physician-led ILD clinic. All referrals and comorbidity management as guided by physician.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Treatable traits model of care","Embedded multidisciplinary clinic with treatable traits model of care.",[9],[25],{"name":26,"affiliation":5,"role":27},"Yuben Moodley, MBSS, FRACP, MD, PHD","PRINCIPAL_INVESTIGATOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":18,"email":33},"Megan Harrison, MBSS (Hons) FRACP","CONTACT","+61 08 6457 3333","megan.harrison@health.wa.gov.au",{"name":26,"role":31,"phone":35,"phoneExt":18,"email":36},"61086152 2222","yuben.moodley@health.wa.gov.au",[38,65],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Sir Charles Gairdner Hospital","NOT_YET_RECRUITING","Perth","Western Australia","6009","Australia","AU",{"type":47,"coordinates":48},"Point",[49,50],115.8614,-31.95224,{"lat":50,"lon":49},[53,57,61,62],{"name":54,"role":31,"phone":55,"phoneExt":18,"email":56},"Megan Harrison, MBBS FRACP","+6147504307","he18696@health.wa.gov.au",{"name":58,"role":31,"phone":59,"phoneExt":18,"email":60},"Lisa Bateman, BSN","+61478 279 934","scgh.ild@health.wa.gov.au",{"name":54,"role":27,"phone":18,"phoneExt":18,"email":18},{"name":63,"role":64,"phone":18,"phoneExt":18,"email":18},"Vidya Navaratnam, FRACP, MD, PHD","SUB_INVESTIGATOR",{"facility":66,"status":67,"city":41,"state":42,"zip":68,"country":44,"countryCode":45,"cosmosGeoPoint":69,"geoPoint":71,"contacts":72},"Fiona Stanley Hospital","RECRUITING","6150",{"type":47,"coordinates":70},[49,50],{"lat":50,"lon":49},[73,77,79,80,82],{"name":74,"role":31,"phone":75,"phoneExt":18,"email":76},"Sharon Maxwell, Bachelor of Nursing","+61 08 6152 2222","sharon.maxwell@health.wa.gov.au",{"name":54,"role":31,"phone":78,"phoneExt":18,"email":33},"61475044307",{"name":26,"role":27,"phone":18,"phoneExt":18,"email":18},{"name":81,"role":64,"phone":18,"phoneExt":18,"email":18},"Megan Harrison, MBBS (Hons) FRACP",{"name":83,"role":64,"phone":18,"phoneExt":18,"email":18},"Jeremy Wrobel, MBBS FRACP PhD",{"type":27,"investigatorFullName":85,"investigatorTitle":86,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Megan Harrison","Dr.",[88,89],{"name":66,"class":6},{"name":39,"class":6},"100564227","treatable-traits-in-interstitial-lung-disease-100564227",false,"NCT06626438","Treatable Traits in Interstitial Lung Disease","TTRILD","Inclusion Criteria: Patients with a new or pre-existing diagnosis of fibrotic ILD who receive care via the Fiona Stanley Hospital (FSH) or Sir Charles Gairdner Hospital (SCGH) ILD service will be invited to participate. This ILD diagnosis must be made through an ILD MDT.\n\nIncluded participants will be aged ≥ 18 years with a physician-confirmed diagnosis of fibrotic ILD. Fibrotic ILD is defined as presence of fibrotic changes on CT in the opinion of the investigator. All ILD subtypes, excluding sarcoidosis, will be included. Participants will need to be able to provide consent to participate and be established on stable ILD treatment for 1 month prior to study initiation.\n\nExclusion Criteria: Participants will be excluded if they have experienced an acute exacerbation 4 weeks prior to starting the study or are expected to experience either a transplant or death during the study period. Active suicidality, severe depression, active psychosis or mania, or other severe psychiatric concerns that require more intensive treatment. Any such participants could be referred for individual therapy and\u002For psychiatric treatment that would be more appropriate for their needs.","ALL","18 Years",{"count":100,"type":101},110,"ESTIMATED","INTERVENTIONAL",[104],"NA","The goal of this clinical trial is to learn if a personalised treatment model of care \"treatable traits\" can improve quality of life and disease progression in patients with interstitial lung disease.\n\nThe main question it aims to answer is, will providing a treatable traits model of care improve health-related quality of life (HRQoL) (primary outcome), symptoms, anxiety, physical activity, and body composition (secondary outcomes).\n\nResearchers will compare the treatable traits model to standard of care.\n\nParticipants in both arms will complete surveys, a Dual-Energy X-Ray Absorptiometry (DEXA) and whole-body composition scan, lung function and blood tests. Those in the intervention (TT) arm will be seen in a multidisciplinary clinic where they are seen by an ILD doctor, physiotherapist, psychologist, and dietitian.",[107],"Interstitial Lung Diseases (ILD)",[109,110,111,112],"treatable traits","interstitial lung disease","pulmonary fibrosis","multidisciplinary","2025-10-01",{"date":115,"type":116},"2025-10-07","ACTUAL",{"date":118,"type":116},"2025-09-03",{"date":120,"type":101},"2027-07",{"name":5,"class":6},2]